Solomon Julie, Card Josefina J, Malow Robert M
Sociometrics Corporation, Los Altos, CA 94022, USA.
Eval Health Prof. 2006 Jun;29(2):162-94. doi: 10.1177/0163278706287344.
The Human Immunodeficiency Virus (HIV) has infected approximately 1.5 million people in the United States. Type 1 translation research (basic research, methods development, and efficacy trials) has yielded multiple efficacious behavioral HIV prevention programs. Type 2 translation research (dissemination and effectiveness studies) has been less prevalent or successful. Adaptation of efficacious interventions for culturally diverse populations has received increasing researcher attention, and empirical validation of adaptation procedures promises to help bridge the gap between Type 1 and Type 2 studies. In this article, the authors briefly discuss the development, testing, and dissemination of efficacious HIV prevention programs and then focus on research-based principles and processes that can guide researchers'adaptation efforts and steps that researchers can take to help empower practitioners to conduct science-based adaptation. Greater collaboration between researchers and service providers to test adaptation frameworks promises to benefit both research and practice.
人类免疫缺陷病毒(HIV)已在美国感染了约150万人。1型转化研究(基础研究、方法开发和疗效试验)已经产生了多个有效的行为HIV预防项目。2型转化研究(传播和效果研究)则不太普遍或成功。针对文化多元人群对有效干预措施进行调整越来越受到研究者的关注,而对调整程序的实证验证有望帮助弥合1型和2型研究之间的差距。在本文中,作者简要讨论了有效HIV预防项目的开发、测试和传播,然后重点关注基于研究的原则和流程,这些原则和流程可以指导研究者的调整工作,以及研究者可以采取的步骤,以帮助从业者有能力进行基于科学的调整。研究者与服务提供者之间加强合作以测试调整框架有望使研究和实践都受益。